Generics markets are gearing up for the expiry of patents on some of the first targeted cancer drugs. Its good news for greater access, but patients want reassurance that switching to generics wont put them [more]
Smartphones give patients the technology not only to record a consultation but also to share it privately, post it on a social network or even upload it to a public website. What does this mean [more]
Knowing what needs to be done is one thing. Making it happen is quite another. Well-informed media stories that highlight shortcomings and failings can help focus minds on the need for urgent action. The media [more]
Patients, doctors, academic researchers and the World Health Organization all want industry to be a lot more open about the drugs they are trialling. The industry is pleading commercial confidentiality. The two sides are locked [more]